InterMune (ITMN) to be Acquired by Roche for $8.3 Billion
August 25, 2014 at 09:45 AM EDT
Shares of InterMune Inc. (ITMN) were up +19.00 or +35.32 percent to $72.80 per share in Monday’s premarket, after news broke on Sunday that Swiss pharmaceutical giant, Roche had entered into a definitive agreement to purchase InterMune for $74.00 per share. InterMune stock closed at $53.80 per share, up +0.59 or +1.11 percent in Friday’s Read the full article... Read the rest of InterMune (ITMN) to be Acquired by Roche for $8.3 Billion at InvestorGuide.com .
